Sponsor:
Georgetown University
Code:
NCT06892275
Conditions
Breast Neoplasm Female
Early Detection of Cancer
Hereditary Breast and Ovarian Cancer Syndrome
Magnetic Resonance Imaging
Eligibility Criteria
Sex: Female
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Enhanced Usual Care
Decision Support
Brief summary:
Conditions
Breast Neoplasm Female
Early Detection of Cancer
Hereditary Breast and Ovarian Cancer Syndrome
Magnetic Resonance Imaging
Study ID
NCT06892275
Start date
Jun 1, 2025
Status verified date
Sep, 2025
Completion date
Dec, 2027
Anticipated
Primary completion date
Jun, 2027
Anticipated
Eligibility Criteria
Sex: Female
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
80 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Screening
Arms
active comparator: Enhanced Usual Care
experimental: Decision Support
Interventions
Enhanced Usual Care
Decision Support
Primary outcome measure
Central contacts
Locations
Georgetown University
Recruiting
Washington D.C., District of Columbia, United States, 20007
Contacts
Principal Investigator:
Claire C. Conley, PhD
Sponsor
Georgetown University
Last update posted
Sep 30, 2025
Last verified
Sep, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Georgetown University on 2025-09-30.